AmBisome is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Astellas Pharma Us, Inc.. The primary component is Amphotericin B.
| Product ID | 0469-3051_5f3f2915-440e-4faa-9e4d-71efae2f50e8 |
| NDC | 0469-3051 |
| Product Type | Human Prescription Drug |
| Proprietary Name | AmBisome |
| Generic Name | Amphotericin B |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 1997-08-11 |
| Marketing Category | NDA / NDA |
| Application Number | NDA050740 |
| Labeler Name | Astellas Pharma US, Inc. |
| Substance Name | AMPHOTERICIN B |
| Active Ingredient Strength | 50 mg/12.5mL |
| Pharm Classes | Lipid-based Polyene Antifungal [EPC],Polyene Antifungal [EPC],Polyenes [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 1997-08-11 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA050740 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1997-08-11 |
| Ingredient | Strength |
|---|---|
| AMPHOTERICIN B | 50 mg/12.5mL |
| SPL SET ID: | f7be6506-4d20-401e-a0ff-02ad7c33158a |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0469-3051 | AmBisome | amphotericin B |
| 39822-1055 | Amphotericin B | Amphotericin B |
| 55150-365 | Amphotericin B | Amphotericin B |
| 62756-233 | Amphotericin B | Amphotericin B |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() AMBISOME 88849383 not registered Live/Pending |
Gilead Sciences, Inc. 2020-03-26 |
![]() AMBISOME 73814641 1598121 Live/Registered |
VESTAR, INC. 1989-07-24 |